Why the study?
What are the early and late outcomes of nonpharmacological treatment (ablation and arrhythmia surgery) for cardiac arrhythmias in adults with congenital heart disease?
What are the early and late outcomes of nonpharmacological treatment (ablation and arrhythmia surgery) for cardiac arrhythmias in adults with congenital heart disease?
This review summarizes the available data on the early and late outcomes of ablation and arrhythmia surgery in adults with congenital heart disease.
Evidence on ablation outcomes in ACHD remains limited; leaves open need for prospective trials before practice change.
Arrhythmias are a major cause of morbidity, mortality and hospital admission in adults with congenital heart disease (CHD). The etiology of arrhythmias in this population is often multifactorial and includes electrical disturbances as part of the underlying defect, surgical intervention or hemodynamic abnormalities. Despite the numerous existing arrhythmia management tools including drug therapy, pacing and ablation, management of arrhythmias in adults with CHD remains difficult and challenging. Owing to improvement in mapping and ablation techniques, ablation and arrhythmia surgery are being performed more frequently in adults with CHD. However, there is little information on the long-term results of these treatment strategies. The purpose of this article is therefore to review the available data on nonpharmacological treatment of cardiac arrhythmias in adult patients with CHD and to give an overview of the available data on the early and late outcomes of these treatment strategies.
No takes yet. Share an insight, caveat, or question.
Koyak et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: